| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Proteasome degradation 0.5046559643018539 2.268015237907389 0.0233282779438654 0.9999989445401088 0.9518930913805436 41 P04439,P28074,P10321,P20618,Q99436,O00231,P49720,P28070,P25787,P49721,P25788,P01889,P60900,Q9UL46,P61289 15 |
| Cholesterol biosynthesis with skeletal dysplasias 0.796641486716595 2.262690131898105 0.0236547975622833 0.9999991314792492 0.9518930913805436 7 Q15125,Q15392 2 |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.8544227293552316 2.0324163123516943 0.0421115280773871 0.9999999999872176 0.9518930913805436 5 P07099 1 |
| Allograft rejection 0.700685143512898 1.943491386940604 0.0519568150505924 0.999999999999969 0.9518930913805436 9 P04439,P10321,P08670,P01889,Q9BY49,P08183 6 |
| Sphingolipid pathway 0.6975632640081971 1.9277828010711828 0.0538821478603845 0.9999999999999906 0.9518930913805436 9 Q06136,Q96G23,O95470 3 |
| 15q112 copy number variation syndrome 0.904903353816806 1.90762210228248 0.0564400763582504 0.999999999999998 0.9518930913805436 4 Q9BSJ2,Q7L576 2 |
| Metabolism of spingolipids in er and golgi apparatus 0.8054826831322832 1.8302829490582433 0.0672076397048759 1.0 0.9518930913805436 5 Q06136,P15291,O95470 3 |
| 3q29 copy number variation syndrome 0.6756619599967804 1.8168993187846132 0.0692325310250412 1.0 0.9518930913805436 9 O75592,O95684 2 |
| Proteoglycan biosynthesis 0.8755041541155235 1.7957517847411348 0.0725340019923455 1.0 0.9518930913805436 4 Q9NX62,Q8NCH0 2 |
| Cytosolic dnasensing pathway 0.6575130645020403 1.7241405140701165 0.0846824797638814 1.0 0.9518930913805436 9 Q7Z434 1 |
| Vitamin dsensitive calcium signaling in depression 0.743369080392005 1.5684452031541145 0.1167772687692396 1.0 1.0 5 Q8NB78,P00390,O60341 3 |
| Genes related to primary cilium development based on crispr 0.6193221584902853 1.5265915970441273 0.126862597833143 1.0 1.0 9 Q8NCM8,Q9Y496,O95684,A0AVF1 4 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.609165041126611 1.5182642843150105 0.1289477875453326 1.0 1.0 14 O60725,P55209,P42166,P11802,Q9UPY3,P49841,O75844,P48729,P50402 9 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.5643225763736752 1.429173316386903 0.1529544250651149 1.0 1.0 22 Q15125,Q15392,P37268,P48449,Q9BWD1,Q16850 6 |
| Nrf2are regulation 0.6216810524766662 1.4258537259397506 0.1539105689341195 1.0 1.0 7 Q96HS1,P09601,P49841 3 |
| Statin inhibition of cholesterol production 0.7778222850560517 1.4172099566822642 0.156421551611511 1.0 1.0 4 Q8WTV0 1 |
| Alzheimers disease 0.4210054576395965 1.3992233663714106 0.1617460116932738 1.0 1.0 76 P28074,Q9UJX6,P45880,P20618,Q99436,Q99570,Q9BUF5,P05067,P49720,O95197,P28070,P25787,P49721,Q00535,Q9NQC3,P21796,P04350 17 |
| Sphingolipid metabolism overview 0.5950854791581407 1.3972099646401437 0.1623504410863132 1.0 1.0 8 Q06136,Q96G23 2 |
| Sphingolipid metabolism integrated pathway 0.5950854791581407 1.3972099646401437 0.1623504410863132 1.0 1.0 8 Q06136,Q96G23 2 |
| Intraflagellar transport proteins binding to dynein 0.6136496120663878 1.3860518785895115 0.1657310628171968 1.0 1.0 7 O43237 1 |
| Alzheimers disease and mirna effects 0.4187071171470805 1.362175805857648 0.1731424092981139 1.0 1.0 77 P28074,P45880,Q9UJX6,P20618,Q99436,Q99570,Q9BUF5,P05067,P49720,P28070,O95197,P25787,P49721,Q00535,Q9NQC3,P21796,P04350 17 |
| Influence of laminopathies on wnt signaling 0.5754166289942203 1.3046237033361665 0.1920210129165163 1.0 1.0 11 O60725,Q9UPY3,P49841,O75844,Q00534,P48729,P50402 7 |
| Ciliopathies 0.5701072449553217 1.2909597053574788 0.1967176503152357 1.0 1.0 13 O43924,Q8NCM8,Q99570,Q9NQH7 4 |
| Sphingolipid metabolism in senescence 0.5711925717849331 1.2770798810907478 0.2015740469700937 1.0 1.0 10 Q06136,Q96G23,P16278 3 |
| Familial partial lipodystrophy fpld 0.5909607478213357 1.2732416005944966 0.2029323227045323 1.0 1.0 7 O60725 1 |
| Il10 antiinflammatory signaling pathway 0.7395972316782919 1.2671757704966002 0.2050924473695925 1.0 1.0 4 P09601 1 |
| 7oxoc and 7betahc pathways 0.5640314455915998 1.2362472625116407 0.2163666675834494 1.0 1.0 9 Q15125,O15118 2 |
| Tlr4 signaling and tolerance 0.779294652757101 1.2289281805490255 0.2190987345844086 1.0 1.0 3 Q15629 1 |
| Disruption of postsynaptic signaling by cnv 0.5963055564332691 1.2103312186635873 0.2261518230270844 1.0 1.0 6 Q7L576 1 |
| Progeriaassociated lipodystrophy 0.5507223852875577 1.1678219642372467 0.2428785864750438 1.0 1.0 10 O60725 1 |
| Vitamin d metabolism 0.7626324800526372 1.1641794402222685 0.2443513003606656 1.0 1.0 3 P38435 1 |
| Regulation of apoptosis by parathyroid hormonerelated protein 0.7102214068113826 1.1517279157063822 0.2494328972250978 1.0 1.0 4 Q9BXK5 1 |
| Metapathway biotransformation phase i and ii 0.527646555713987 1.1517267911200846 0.2494333594914342 1.0 1.0 20 Q16850,P78417,P00390,P07099,P21964,Q86UY6,Q8NCH0,Q7LGA3 8 |
| Hostpathogen interaction of human coronaviruses interferon induction 0.7089059199348917 1.1465620183845082 0.2515626816057379 1.0 1.0 4 Q7Z434 1 |
| Praderwilli and angelman syndrome 0.6431866051257038 1.1379125867174649 0.2551569849402639 1.0 1.0 5 Q7L576,Q00534,P11802 3 |
| T cell receptor and costimulatory signaling 0.7461484593837544 1.1003055821876735 0.2711990007800891 1.0 1.0 3 P19174,P49841 2 |
| Mitochondrial complex iii assembly 0.5360555482082454 1.0922178357403776 0.274737364739765 1.0 1.0 11 P22695,Q6DKK2 2 |
| Camkk2 pathway 0.5361976613474049 1.0902471123998607 0.2756043053327774 1.0 1.0 10 Q14012,Q9Y3D6,O76024,P09601 4 |
| Apoptosis modulation by hsp70 0.7356442577030822 1.0597384497617812 0.2892636052956145 1.0 1.0 3 O95831,Q13546 2 |
| Reninangiotensinaldosterone system raas 0.7332230006588705 1.0504058539428476 0.2935315553637654 1.0 1.0 3 Q14012 1 |
| P53 transcriptional gene network 0.5279529401690556 1.04658874345049 0.2952892957904915 1.0 1.0 8 Q7LG56,P43246,P04066,Q709F0 4 |
| Oxidation by cytochrome p450 0.6206914278847344 1.0410230599899315 0.2978648459719144 1.0 1.0 5 O43169,Q16850 2 |
| Ketogenesis and ketolysis 0.6180543905246901 1.029689513697012 0.3031557797000759 1.0 1.0 5 O43772 1 |
| Ethanol effects on histone modifications 0.5223540037196783 1.0173478751559244 0.3089879691749551 1.0 1.0 8 Q9H9T3,O14929,P00374 3 |
| Kennedy pathway from sphingolipids 0.6682774593882205 0.9875694748076748 0.3233635420934413 1.0 1.0 4 P35790 1 |
| Cell cycle 0.3412377749064647 0.9819038512528026 0.3261472182676486 1.0 1.0 45 Q99640,Q9UJX6,P49736,P11802,Q9UJX3,P33991,P49841,O75419,Q9UJX2,Q9Y619,O14757,Q14566,P06493,Q00534,Q9UJX4,P25205 16 |
| Triacylglyceride synthesis 0.6028666177102076 0.9645683221226328 0.3347610723615992 1.0 1.0 5 O00116,O15228,Q9HCL2 3 |
| Mammary gland development pathway pregnancy and lactation stage 3 of 4 0.661681125916194 0.961913577705721 0.3360930175848819 1.0 1.0 4 P06753,P61201 2 |
| Complement system in neuronal development and plasticity 0.5076469334797067 0.9407217569521032 0.3468474663895686 1.0 1.0 8 Q5KU26,Q9NR28,Q8N3R9 3 |
| Heme biosynthesis 0.6542907180385321 0.9332450374145616 0.3506934660198406 1.0 1.0 4 P22830,P36551,P08397 3 |
| Sterol regulatory elementbinding proteins srebp signaling 0.467697392529505 0.9281784984432544 0.3533149858636104 1.0 1.0 26 Q9UKV5,Q8WTV0,O95487,P37268,P48449,Q16850,Q9HCL2 7 |
| Glycerophospholipid biosynthetic pathway 0.5179034860391715 0.9095360978446284 0.3630672123240555 1.0 1.0 7 O00116,O15228,P48651,Q9HCL2 4 |
| Autophagy 0.6479859894921223 0.9088595674125518 0.3634242587170893 1.0 1.0 4 P54619,Q99570,P42345 3 |
| G1 to s cell cycle control 0.4728711866753707 0.9043571570715752 0.3658060480372758 1.0 1.0 24 P49642,Q99640,P49736,P11802,P33991,O75419,Q9Y619,Q14566,P06493,P49643,Q00534,P25205 12 |
| Ferroptosis 0.4848318380437152 0.8922836187687319 0.3722409323044746 1.0 1.0 20 Q9NZ45,P09601,P37268 3 |
| Mthfr deficiency 0.5271286779007838 0.8814881691352094 0.3780536546989999 1.0 1.0 6 P21964,P35790 2 |
| Intracellular trafficking proteins involved in cmt neuropathy 0.4955554360414594 0.8780169365319156 0.379934527650047 1.0 1.0 8 P07196,Q9NR77 2 |
| Estrogen receptor pathway 0.6870709022889117 0.8743737361033258 0.3819147555105961 1.0 1.0 3 Q9HCL2 1 |
| Striated muscle contraction pathway 0.6827731092436986 0.8582142167193946 0.390774187181377 1.0 1.0 3 P06753,P08670 2 |
| Dna mismatch repair 0.4799125810197794 0.8335098027323143 0.4045572716049588 1.0 1.0 18 Q9UQ84,Q9Y2S7 2 |
| Apoptosis 0.4862108543004917 0.829812579748701 0.4066447572395999 1.0 1.0 8 Q99590,Q13546,Q9NR28 3 |
| Zinc homeostasis 0.8491424571228561 0.8255617748255247 0.4090527264409171 1.0 1.0 2 Q8TAD4 1 |
| Adipogenesis 0.480006582792925 0.7928926590324518 0.4278403647033455 1.0 1.0 12 Q9NZ45,P43490 2 |
| Copper homeostasis 0.5612471023837998 0.7882770789230553 0.4305346518448742 1.0 1.0 5 P05067,P49841 2 |
| Hedgehog signaling pathway wp4249 0.6607681311724101 0.7763198249111268 0.4375601703876297 1.0 1.0 3 Q9Y496 1 |
| Oxysterols derived from cholesterol 0.4867369304422582 0.7568779944370319 0.4491229601618527 1.0 1.0 7 Q15125 1 |
| Nocgmppkg mediated neuroprotection 0.6537593616251193 0.7505726674000581 0.4529098756493674 1.0 1.0 3 P07196 1 |
| Nrf2 pathway 0.4558682817860755 0.7349448291755365 0.4623730949487887 1.0 1.0 21 Q14914,P11413,P48163,Q8N1S5,P09601,Q99735,P00390 7 |
| Cholesterol biosynthesis pathway 0.4689196924625856 0.7338845842334419 0.4630190832428225 1.0 1.0 12 Q16850,P37268,P48449 3 |
| Endothelin pathways 0.4803840744026781 0.726187741084497 0.467723686092681 1.0 1.0 7 P42892,P00403 2 |
| Regulation of wnt bcatenin signaling by small molecule compounds 0.6431044321887325 0.7117906951658051 0.4765943954750067 1.0 1.0 3 P49841 1 |
| Sulfation biotransformation reaction 0.6340950079244715 0.679368956403898 0.4969041144760517 1.0 1.0 3 P00390 1 |
| Novel intracellular components of rigilike receptor rlr pathway 0.4423641085968535 0.6085106580909124 0.542848839299994 1.0 1.0 8 Q7Z434,Q13546 2 |
| Eicosanoid synthesis 0.776688834441722 0.5827343673868599 0.5600721338245536 1.0 1.0 2 P09960 1 |
| Vitamin d receptor pathway 0.4373726448020151 0.5743644225456241 0.5657212228550541 1.0 1.0 10 Q96KA5,P08183,P11413,Q5VV42 4 |
| Nuclear receptors metapathway 0.3017077076630491 0.550375390171814 0.5820619246553811 1.0 1.0 46 P28161,O00170,Q14914,P11413,P48163,Q8N1S5,P09601,P28370,P06493,Q99735,Q8IWT6,P50416,P23786,P08183,P00390,Q9HCL2,Q15067 17 |
| Urea cycle and related diseases 0.76128806440322 0.5346363011776836 0.592901376535413 1.0 1.0 2 Q9Y619 1 |
| Initiation of transcription and translation elongation at the hiv1 ltr 0.4350007272171726 0.5137206967073839 0.6074472796990475 1.0 1.0 7 Q9H3P2,O00267,Q8IXH7 3 |
| Wntbetacatenin signaling pathway in leukemia 0.5389241364005979 0.5066647187463359 0.6123900897645074 1.0 1.0 4 P49841 1 |
| Eicosanoid metabolism via lipooxygenases lox 0.4877332574008688 0.4931805751939945 0.621885001817829 1.0 1.0 5 Q14914,Q15067 2 |
| Glutathione metabolism 0.4339739661574147 0.4621588609549446 0.6439674024055999 1.0 1.0 6 P11413,P28161,P00390 3 |
| Physicochemical features and toxicityassociated pathways 0.4128945077751113 0.445928912939444 0.6556485962802077 1.0 1.0 14 P07197,P49841,Q14012,P61160,Q13153,P07196,P19174 7 |
| Nitric oxide metabolism in cystic fibrosis 0.4702974788655347 0.4283588175224305 0.6683899027811568 1.0 1.0 5 O60678,Q86X55 2 |
| Ccl18 signaling pathway 0.4057691840521834 0.4274699094847735 0.6690370974022533 1.0 1.0 9 P07196,P08670 2 |
| Dna replication 0.3851494425289496 0.3989682542791977 0.6899165957580882 1.0 1.0 26 P49642,P40937,P49736,P33991,O75419,Q9Y619,Q9Y2S7,Q14566,P49643,P28340,P25205,Q07864 12 |
| Neuroinflammation 0.7080854042702134 0.3813097669940846 0.7029734071376257 1.0 1.0 2 P00403 1 |
| Type ii diabetes mellitus 0.7080854042702134 0.3813097669940846 0.7029734071376257 1.0 1.0 2 Q05655 1 |
| Retinoblastoma gene in cancer 0.2970294837241818 0.3747024145866428 0.7078817963042816 1.0 1.0 42 Q14566,Q16204,Q07864,P26358,P00374,O75419,P33993,Q9Y619,O14757,P06493,P40937,P23921,P11802,P33991,Q00534,P40938,P49642,P31350,P25205,Q14527 20 |
| Translation factors 0.3472137584318511 0.3702029087960662 0.7112313094131553 1.0 1.0 34 P55010,O75153,Q13144,O00303,Q15056,O15372,Q9NR50 7 |
| Iron metabolism in placenta 0.7007350367518375 0.361917977524175 0.717413325228087 1.0 1.0 2 P02786 1 |
| Eicosanoid metabolism via cyclooxygenases cox 0.4470063189012536 0.3462053904074801 0.7291883639731818 1.0 1.0 5 Q14914 1 |
| Vasopressinregulated water reabsorption 0.3903072844022494 0.3364887649686022 0.7365023224263461 1.0 1.0 15 Q9UJW0,O43237 2 |
| Liver x receptor pathway 0.6818340917045851 0.3143041000126594 0.7532900845416681 1.0 1.0 2 P49327 1 |
| Pilocytic astrocytoma 0.6702835141757086 0.2868796130219578 0.7742045011193102 1.0 1.0 2 Q06124 1 |
| Ciliary landscape 0.3273397409816177 0.2845700279309811 0.7759735764549327 1.0 1.0 90 O15173,O60942,Q9H9Q2,P31150,Q9NQH7,Q14566,P07196,P16278,P49736,Q96P70,A0AVF1,Q9H9A5,Q7L5N1,P33991,Q92600,P07197,Q96S59,Q96KP1,P08670,P43246,Q9UNS2,Q99567,P61201,P10619,Q96A65,Q13868,Q9BT78,Q9Y312,P25205 29 |
| Pyrimidine metabolism 0.3035350959731522 0.2588473514453679 0.7957530213977435 1.0 1.0 39 P30876,Q9BUI4,P31350,Q9NR33,Q9Y2S7,Q7LG56,Q9H773 7 |
| Tryptophan metabolism 0.3725711954225837 0.2574186613703482 0.7968555984741625 1.0 1.0 14 Q15392 1 |
| Thermogenesis 0.365208182960818 0.2486208212590193 0.8036541010837357 1.0 1.0 23 O43772,P23786,P50416,O60341 4 |
| Nucleotide excision repair 0.3645492233846398 0.2452940410696973 0.8062287653769549 1.0 1.0 23 P18074,P40937,P19447,Q16531,P41208,Q9NR33,Q9Y2S7,P28340,Q07864 9 |
| Fluoropyrimidine activity 0.3638098843414008 0.2278645011450267 0.8197515807396751 1.0 1.0 12 P18074,P31350,Q06203,P00374 4 |
| Selenium micronutrient network 0.3557223593695351 0.2147218749576632 0.8299841666010097 1.0 1.0 9 Q8NFF5,P00390,Q8WTV0 3 |
| Photodynamic therapyinduced ap1 survival signaling 0.4280210157618273 0.1813007601222304 0.8561315094246167 1.0 1.0 4 P49327,P07900,Q07820 3 |
| Pyrimidine metabolism and related diseases 0.3388702841552155 0.1613528006937943 0.8718155390772595 1.0 1.0 8 Q7LG56 1 |
| Nsp1 from sarscov2 inhibits translation initiation in the host cell 0.3465824921069035 0.160779629941584 0.872266969446658 1.0 1.0 12 P55010,O15372 2 |
| Oxidative stress response 0.4448635930543304 0.14150292820636 0.8874726469454777 1.0 1.0 3 P09601 1 |
| Mevalonate arm of cholesterol biosynthesis pathway 0.3349067837296788 0.1395416727030228 0.8890221279868984 1.0 1.0 9 P37268 1 |
| Dna repair pathways full network 0.2579725591026907 0.137674252731285 0.8904978689405723 1.0 1.0 46 Q9UQ84,P41208,Q9NR33,Q9Y2S7,Q9BXW9 5 |
| Amyotrophic lateral sclerosis als 0.3234959158957022 0.1106134773812768 0.9119228596696404 1.0 1.0 8 Q9BUN8,P07196,O96008 3 |
| Srebf and mir33 in cholesterol and lipid homeostasis 0.3862193372141913 0.0960648906835239 0.9234690354813412 1.0 1.0 4 P42345,P49327 2 |
| Nonhomologous end joining 0.4159663865546238 0.0944742140864485 0.924732464992268 1.0 1.0 3 P78527,P12956 2 |
| Signal transduction through il1r 0.5187259362968148 0.0568539547898714 0.9546615337001384 1.0 1.0 2 Q9BQ95 1 |
| Apoptosisrelated network due to altered notch3 in ovarian cancer 0.3140810437527114 0.0527432588686944 0.9579364713798172 1.0 1.0 12 P08670 1 |
| Base excision repair 0.3164525853814436 0.0485803953259161 0.9612536937785856 1.0 1.0 14 Q9Y2S7 1 |
| P38 mapk signaling pathway 0.3077462320364525 0.048468304912371 0.9613430237582424 1.0 1.0 6 Q13546,P04792,P62993,P42224,P63000 5 |
| Nucleotide metabolism 0.3143225143856046 0.0421916875596908 0.966345889027772 1.0 1.0 14 Q7LG56,P00374 2 |
| Immune response to tuberculosis 0.3669467787114865 0.0387675035083298 0.9690757537916757 1.0 1.0 3 P42224,Q03518 2 |
| Biomarkers for pyrimidine metabolism disorders 0.2956648154369543 0.0328319713623391 0.9738085824893148 1.0 1.0 8 Q7LG56 1 |
| Heart development 0.4781239061953095 0.0327870934053564 0.9738443706507648 1.0 1.0 2 Q06124 1 |
| Interactions between loxl4 and oxidative stress pathway 0.3494397759103662 0.0254793764526953 0.9796725983535016 1.0 1.0 3 Q8TAG9,Q9BQ95 2 |
| Hematopoietic stem cell gene regulation by gabp alphabeta complex 0.3385854341736717 0.0187454238525253 0.9850441916166932 1.0 1.0 3 P26358,Q07820 2 |
| Atr signaling 0.4305215260763037 0.0176962724211315 0.9858811543603094 1.0 1.0 2 O14757 1 |
| Tnfrelated weak inducer of apoptosis tweak signaling pathway 0.3083848079932579 0.0118834224889029 0.9905186238203753 1.0 1.0 5 Q13546 1 |
| Mecp2 and associated rett syndrome 0.3093075103190417 0.0117772423620646 0.9906033373758788 1.0 1.0 18 Q00013,Q99640,P67809,P52597 4 |
| Ovarian infertility 0.346867343367168 0.0094889007011037 0.9924290662452842 1.0 1.0 2 P11802 1 |
| Metastatic brain tumor 0.307422969187677 0.0048369018621189 0.9961407257304546 1.0 1.0 3 P04637,Q00534 2 |
|
|
